lmmunomodulation - a disease-modifying avenue for treatment of Huntington's disease?

被引：3
|
作者：
Bjorkqvist, Maria [1 ]
机构：
[1] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Brain Dis Biomarker Unit, BMC A10, S-22184 Lund, Sweden
来源：
JOURNAL OF NEUROCHEMISTRY | 2016年 / 137卷 / 05期
关键词：
PATHWAY;
D O I：
10.1111/jnc.13539
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：670 / 672
页数：3
相关论文
共 50 条
  • [31] Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease
    O'Hara, Darren M.
    Kalia, Suneil K.
    Kalia, Lorraine V.
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (15) : 3080 - 3089
  • [32] Taking the next steps in the treatment of Alzheimer's disease: Disease-modifying agents
    Salloway, Stephen
    CNS SPECTRUMS, 2008, 13 (03) : 11 - 14
  • [33] Towards Disease-Modifying Treatment of Alzheimer's Disease: Drugs Targeting β-Amyloid
    Frisardi, V.
    Solfrizzi, V.
    Imbimbo, B. P.
    Capurso, C.
    D'Introno, A.
    Colacicco, A. M.
    Vendemiale, G.
    Seripa, D.
    Pilotto, A.
    Capurso, A.
    Panza, F.
    CURRENT ALZHEIMER RESEARCH, 2010, 7 (01) : 40 - 55
  • [34] Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease
    Dobson, Ruth
    Patterson, Katherine
    Malik, Reshad
    Mandal, Uttara
    Asif, Hina
    Humphreys, Ros
    Payne, Michael
    O-Charoenrat, Eng
    Huzzey, Lauren
    Clare, Adam
    Green, Kate
    Morton, Maija
    Sohrabi, Catrin
    Singh, Navreen
    Pasupathy, Amirtha
    Patel, Milan
    Whiteman, Sam
    Maxmin, Kate
    Bass, Nicholas
    Gupta, Bhavya
    Cooper, Claudia
    Marshall, Charles
    Weil, Rimona Sharon
    Mummery, Catherine J.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (09): : 796 - 803
  • [35] Inhibition of γ-secretase as an approach to disease-modifying treatment of Alzheimer's disease.
    Jacobs, RT
    Bernstein, PR
    Ohnmacht, CJ
    Rosamond, JD
    Shenvi, AB
    Simpson, TR
    Ciaccio, P
    Ledonne, NC
    Liu, F
    Piser, TM
    Stahl, J
    Tian, GC
    Greenberg, BD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U968 - U968
  • [36] Publisher Correction: Questions swirl around failures of disease-modifying Huntington’s drugs
    Cormac Sheridan
    Nature Biotechnology, 2021, 39 : 893 - 893
  • [37] DEVELOPMENT OF DISEASE MODIFYING THERAPIES IN HUNTINGTON'S DISEASE
    Bates, G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (10):
  • [38] Publisher Correction: Questions swirl around failures of disease-modifying Huntington’s drugs
    Cormac Sheridan
    Nature Biotechnology, 2021, 39 : 1017 - 1017
  • [39] Multitarget disease-modifying therapy in Parkinson's disease?
    Calabresi, Paolo
    Di Filippo, Massimiliano
    LANCET NEUROLOGY, 2015, 14 (10): : 975 - 976
  • [40] Disease-modifying drugs and vaccines for Alzheimer's disease
    Cummings, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S40 - S40
12345